ACE gene polymorphism and serum ACE activity in Iranians type II diabetic patients with macroalbuminuria

Molecular and Cellular Biochemistry

Volumn 346, Issue 1-2, 2011, Pages 23-30

  Felehgari, Vahid ^a,b   Rahimi, Zohreh ^a,b   Mozafari, Hadi ^a   Vaisi Raygani, Asad ^b  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

ACE activity; ACE genotypes; Captopril; Losartan; Macroalbuminuria; Type 2 diabetes mellitus

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; ASPARTIC ACID; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN;

ADULT; ALBUMINURIA; ARTICLE; BLOOD SAMPLING; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DISEASE ASSOCIATION; DRUG EFFICACY; ENZYME ACTIVITY; ETHNIC GROUP; FEMALE; GENE DELETION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERTENSION; IRAN; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; RISK FACTOR;

ALBUMINURIA; DIABETES MELLITUS, TYPE 2; GENOTYPE; HUMANS; IRAN; LIPIDS; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC;

EID: 78751604626     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-010-0587-2     Document Type: Article

References (26)

1. A Vaisi-Raygani Z Rahimi H Nomani, et al. 2007 The presence of apolipoprotein ε4 and ε2 alleles augments the risk of coronary artery disease in type 2 diabetic patients Clin Biochem 40 1150 1156 1:CAS:528:DC%2BD2sXhtVWms7vN 10.1016/j.clinbiochem.2007.06.010 17689519 (Pubitemid 47379326)
2. S Hadjadj F Fumeron R Roussel, et al. 2008 Prognostic value of the insertion/deletion polymorphism of the ACE gene in type 2 diabetic subjects Diabetes Care 31 1847 1852 1:CAS:528:DC%2BD1cXhtFKku7bM 10.2337/dc07-2079 18523145
3. PK Jacobsen 2005 Preventing end stage renal disease in diabetic patients: genetic aspect (part I) J Renin Angiotensin Aldosterone Syst 6 1 14 1:CAS:528:DC%2BD2MXlsFejtrc%3D 10.3317/jraas.2005.001 16088846
4. I Arfa A Abid S Nouira, et al. 2008 Lack of association between the angiotensin-converting enzyme gene (I/D) polymorphism and diabetic nephropathy in Tunisian type 2 diabetic patients J Renin Angiotensin Aldosterone Syst 9 32 36 1:CAS:528:DC%2BD1cXlsFSmur8%3D 10.3317/jraas.2008.002 18404607 (Pubitemid 351546632)
5. P Ruggenenti P Bettinaglio F Pinares, et al. 2008 Angiotensin converting enzyme insertion/deletion polymorphism and renoprotection in diabetic and nondiabetic nephropathies Clin J Am Soc Nephrol 3 1511 1525 10.2215/CJN.04140907 18550651
6. S Movva RV Alluri S Komandur, et al. 2007 Relationship of angiotensin-converting enzyme gene polymorphism with nephropathy associated with type 2 diabetes mellitus in Asian Indians J Diabetes Complications 21 237 241 10.1016/j.jdiacomp.2006.07.001 17616353 (Pubitemid 47002317)
7. M Azimi-Nezhad M Ghayour-Mobarhan MR Parizadeh, et al. 2008 Prevalence of type 2 diabetes mellitus in Iran and its relationship with gender, urbanisation, education, marital status and occupation Singapore Med J 49 571 576 1:STN:280:DC%2BD1crht1OgsA%3D%3D 18695867
8. Z Rahimi A Merat N Gerard, et al. 2006 Implications of the genetic epidemiology of globin haplotypes linked to the sickle gene in Southern Iran Hum Biol 78 719 731 10.1353/hub.2007.0016 17564250
9. A Nikzamir M Nakhjavani A Esteghamati, et al. 2008 Correlates of ACE activity in macroalbuminuric type 2 diabetic patients treated with chronic ACE inhibition Nephrol Dial Transplant 23 1274 1277 1:CAS:528:DC%2BD1cXjs12lsLc%3D 10.1093/ndt/gfm745 17986476 (Pubitemid 351767484)
10. A Nikzamir A Esteghamati M Feghhi, et al. 2009 The insertion/deletion polymorphism of the angiotensin-converting enzyme gene is associated with progression, but not development, of albuminuria in Iranian patients with type 2 diabetes J Renin Angiotensin Aldosterone Syst 10 109 114 1:CAS:528: DC%2BD1MXhtVChtL7K 10.1177/1470320309104872 19502259
11. American Diabetes Association 2004 Nephropathy in diabetes Diabetes Care 27 S79 S83 10.2337/diacare.27.2007.S79
12. WHO Study Group Report of a WHO consultation: Part 1 (1999) Diagnosis and classification of diabetes mellitus. World Health Organization, Geneva
13. Old JM, Higgs DR (1983) Gene analysis. In: Weatherall DJ (ed) Methods in hemotology. Vol 6. The thalassemias. Livingstone, UK, pp 74-101
14. M Nakhjavani F Esfahnian A Jahanshahi, et al. 2007 The relationship between the insertion/deletion polymorphism of the ACE gene and hypertension in Iranian patients with type 2 diabetes Nephrol Dial Transplant 22 2549 2553 1:CAS:528:DC%2BD2sXhtVSgsbrP 10.1093/ndt/gfm252 17478487 (Pubitemid 47365519)
15. GA Maguire CP Price 1985 A continuous monitoring spectrophotometric method for the measurement of angiotensin-converting enzyme in human serum Ann Clin Biochem 22 204 210 1:CAS:528:DyaL2MXitFOhs70%3D 2988402
16. A Kumar K Mohindru PK Sehajpal 2005 Angiotensin-I converting enzyme polymorphism and diabetic nephropathy in North India In J Hum Genet 5 279 283 1:CAS:528:DC%2BD28XltVejtQ%3D%3D
17. FY Tang FY Liu XW Xie 2008 Association of angiotensin converting enzyme and endothelial nitric oxide synthase gene polymorphisms with vascular disease in ESRD patients in a Chinese population Mol Cell Biochem 319 33 39 1:CAS:528:DC%2BD1cXht1Krtr%2FM 10.1007/s11010-008-9874-6 18629615
18. DPK Ng BC Tai D Koh, et al. 2005 Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 and comprising 14727 subjects Diabetologica 14 1008 1016 10.1007/s00125-005-1726-2 (Pubitemid 40767996)
19. S Eleni K Dimitrios P Vaya, et al. 2008 Angiotensin-I converting enzyme gene and I/D polymorphism distribution in the Greek population and a comparison with other European populations J Genetics 87 91 93 1:CAS:528: DC%2BD1cXntFynsLc%3D 10.1007/s12041-008-0013-7 (Pubitemid 351716895)
20. JB Zhou JK Yang JK Lu, et al. 2010 Angiotensin-converting gene polymorphism is associated with type 2 diabetes: a meta-analysis Mol Biol Rep 37 67 73 10.1007/s11033-009-9648-6 19655271
21. HH Parving D de Zeeuw ME Cooper, et al. 2008 ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathy J Am Soc Nephrol 19 771 779 1:CAS:528:DC%2BD1cXkvFOhtrw%3D 10.1681/ASN.2007050582 18199798
22. SK Ha S Yong Lee H Su Park, et al. 2000 ACE DD genotype is more susceptible than ACE II and ID genotypes to the antiproteinuric effect of ACE inhibitors in patients with proteinuric non-insulin-dependent diabetes mellitus Nephrol Dial Transplant 15 1617 1623 1:CAS:528:DC%2BD3cXnvV2lsbk%3D 10.1093/ndt/15.10.1617 11007831
23. WY So RC Ma R Ozaki, et al. 2006 Angiotensin-converting enzyme (ACE) inhibition in type 2 diabetic patients: interaction with ACE insertion/deletion polymorphism Kidney Int 69 1438 1443 1:CAS:528:DC%2BD28XjsVWrs70%3D 16395257
24. R Kalaitzidis GL Bakris 2009 Effects of angiotensin II receptor blockers on diabetic nephropathy J Hypertension 27 Suppl 5 S15 S21 1:CAS:528: DC%2BD1MXot1eqs7g%3D 10.1097/01.hjh.0000357904.71080.7d
25. A Vaisi-Raygani Z Rahimi H Tavilani A Pourmotaabed 2010 Butyrylcholinesterase K variant and the APOE-epsilon4 allele work in synergy to increase the risk of coronary artery disease especially in diabetic patients Mol Biol Rep 37 2083 2091 1:CAS:528:DC%2BC3cXis1Wls7g%3D 10.1007/s11033-009-9666-4 19685167
26. G Zoppini G Targher M Chonchol, et al. 2009 Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes Nutr Metab Cardiovas 19 580 586 1:CAS:528: DC%2BD1MXhtlKqt7vE 10.1016/j.numecd.2008.11.003